Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001811511-21-000001
Filing Date
2021-09-09
Accepted
2021-09-09 15:25:12
Documents
1
Effectiveness Date
2021-09-09
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7195
  Complete submission text file 0001811511-21-000001.txt   8246
Mailing Address 83 NEWBURY STREET SUITE 4 BOSTON MA 02116
Business Address 83 NEWBURY STREET SUITE 4 BOSTON MA 02116 617-823-2399
Ankyra Therapeutics, Inc. (Filer) CIK: 0001811511 (see all company filings)

EIN.: 843712498 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-412827 | Film No.: 211244311